Archives: Productos

  • 27 de July de 2021
    Prognostic and predictive molecular in vitro test to determine the risk of recurrence and the absolute benefit of chemotherapy over…
  • 24 de August de 2021
    The most comprehensive tumor test to determine Homologous Recombination Deficiency (HDR) Status by studying the BRCA genes in patients with…
  • 24 de August de 2021
    La prueba más completa para determinar el estado de deficiencia de la recombinación homóloga (HDR) estudiando los genes BRCA y…
  • 16 de February de 2022
    Chimerism monitoring by NGS
  • 17 de February de 2022
    Convenient and efficient library prep for interrogating the control region of the mitochondrial genome with minimal DNA input and optimum…
  • 17 de February de 2022
    Convenient and cost-effective library prep for sequencing the whole mitochondrial genome with minimal DNA input and exceptional data recovery.
  • 15 de September de 2022
    NGS-based solution for identification, genotyping and prediction of drug resistance of Mycobacterium tuberculosis
  • 17 de October de 2022
    Neonatal screening tests for severe combined immunodeficiency, X-linked agammaglobulinaemia or Bruton's disease and spinal muscular atrophy.
  • 2 de November de 2022
    Pretreatment of the patient's serum for detection of antibodies against blood group antigens
  • 2 de November de 2022
    Prognostic test to determine tumour aggressiveness and 10-year disease-specific mortality in patients with primary localised prostate cancer.